Nanome is the first virtual reality software company to launch an immersive real-time collaboration platform for scientific discovery and is changing the way we understand and interact with science at the molecular level. The software environment allows users to visualize, modify, and simulate proteins, chemical compounds, and nucleic acids to accelerate scientific decision-making. The platform facilitates effective communication of data and integrates with existing computational chemistry workflows—features that have led to the adoption of the San Diego–based company's enterprise solution by several pharmaceutical and biotech companies worldwide.
Nanome is a virtual reality software company that offers a collaborative XR software platform for molecular design. The platform accelerates existing computational workflows at the molecular scale and unlocks more scientists to leverage powerful molecular computations + AI. The San Diego, California-based company was launched in 2015 by Edgardo Leija, Samuel Hessenauer, Keita Funakawa, and Steven McCloskey.
Total Funding: $6.4 M
Funding Stage: Funded
Business Stage: Scaling Up
Market: B2B, B2C
Company Size: 1 to 25
Founded: 2015
Business Development Associate
San Diego, California
Drug Discovery Software Business Development Representative & Account Manager
San Diego, California
